help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 9, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2564
A more recent version of this article appeared on August 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/8/3041    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SORIANO-GUILLEN, L.
Right arrow Articles by LAHLOU, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SORIANO-GUILLEN, L.
Right arrow Articles by LAHLOU, N.

Submitted on November 28, 2005
Accepted on May 2, 2006

ACTIVATING MUTATIONS IN THE LH RECEPTOR GENE: A HUMAN MODEL OF NON FSH-DEPENDENT INHIBIN PRODUCTION AND GERM CELL MATURATION

Leandro SORIANO-GUILLEN MD, Valerie MITCHELL PhD, Jean-Claude CAREL MD, Patrick BARBET MD, Marc ROGER MD, and Najiba LAHLOU MD*

Department of Pediatric Endocrinology, CHU Cochin - Saint Vincent de Paul, Paris, France, 75014 (L.S-G, J.-C.C.); the Department of Endocrinology, Hospital Infantil Nino Jesus, Madrid, Spain (L.S.-G.); the Laboratory of Spermiology and Histology, CHRU - Faculty of Medicine, Lille, France (V.M.); the Laboratory of Pathology, CHU Cochin - Saint Vincent de Paul, Paris, France (J.-P.B.); and the Laboratory for Hormone Biology, CHU Cochin - Saint Vincent de Paul, Paris, France (M.R., N.L)

* To whom correspondence should be addressed. E-mail: najiba.lahlou{at}svp.aphp.fr.

Context: Familial male-limited precocious puberty (FMPP) is a dominant autosomal genetic disease caused by activating LH receptor gene mutations, clinically expressed only in males. In preliminary studies, in addition to the expected testosterone increase, we found high inhibin B levels before the age of normal puberty.

Objectives: To assess the cellular origin of serum inhibin thanks to testis section immunostaining.

Main Outcome Measures: Serum testosterone, gonadotropin, inhibin B, pan-aC-inhibin, and anti-mullerian hormone (AMH) levels were measured. Immunostaining was performed using specific anti-a- and anti-b-subunit antibodies.

Subjects and Methods: Five boys from three families (mutation M398T or I542L) were investigated at onset (2 to 6 yr), on ketoconazole treatment, and at adolescence. Testis biopsies were performed in 3 subjects before the disease was fully characterized.

Results: The high testosterone levels were suppressed by ketoconazole. AMH levels were inversely related to testosterone: low at diagnosis, elevated after testosterone suppression. Despite FSH suppression, inhibin B and pan-{alpha}C-inhibin levels were high from clinical onset to adolescence. Biopsy specimens showed normal Sertoli cell complement and germ cell maturation until the spermatocyte II stage. Sertoli and Leydig cells displayed positive inhibin {alpha}-subunit immunostaining. Only Leydig cells and spermatogonia stained positively for the inhibin {beta}B-subunit.

Conclusion: FMPP is a unique model of inhibin B secretion, demonstrating that Leydig cells can produce significant amounts of the dimeric molecule. Our results also suggest that the pubertal FSH rise is not required for full expression of the two inhibin B genes and for the initiation of germ cell maturation.


Key words: familial male-limited precocious puberty • LH receptor • inhibin • Sertoli cell • germ cell • Leydig cell




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. E. Chemes, R. A. Rey, M. Nistal, J. Regadera, M. Musse, P. Gonzalez-Peramato, and A. Serrano
Physiological Androgen Insensitivity of the Fetal, Neonatal, and Early Infantile Testis Is Explained by the Ontogeny of the Androgen Receptor Expression in Sertoli Cells
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4408 - 4412.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. De Luca, V. Mitchell, M. Wasniewska, T. Arrigo, M. F. Messina, M. Valenzise, L. de Sanctis, and N. Lahlou
Regulation of spermatogenesis in McCune-Albright syndrome: lessons from a 15-year follow-up.
Eur. J. Endocrinol., June 1, 2008; 158(6): 921 - 927.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. T. Page, J. K. Amory, and W. J. Bremner
Advances in Male Contraception
Endocr. Rev., June 1, 2008; 29(4): 465 - 493.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society